Meejung Ahn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Meejung Ahn has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Taekyun Shin
College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju 63243, Korea
13 shared publications - Jeongtae Kim
Department of Anatomy, Jeju National University College of Medicine, Jeju 63243, Korea
9 shared publications - Changjong Moon
College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University, Gwangju 61186, Korea
5 shared publications - Hun Hwan Kim
Department of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University, 501 Jinju-daero, Jinju 52828, Republic of Korea
5 shared publications - Kyungsook Jung
Functional Biomaterials Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 56212, Korea
5 shared publications - Pritam Bhagwan Bhosale
Department of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University, 501 Jinju-daero, Jinju 52828, Republic of Korea
5 shared publications
Latest Publications
- Open Access
- 1 February 2026
- Published by Asian Australasian Association of Animal Production Societies in Animal Bioscience
- Vol. 39 (2) , 250478
Assessment of the safety of Chlorella fusca grown in refined swine manure liquid fertilizer for bioresource applications
Objective: Chlorella fusca, a microalga with promising applications in sustainable biotechnology, is of growing interest for its nutritional value, environmental benefits, and bioactive properties. This study investigated the safety and viability of cultivating C. fusca in refined liquid fertilizer derived from pig manure.Methods: Refined liquid fertilizer derived from swine manure was used as a nutrient medium for cultivating C. fusca. To compare its biochemical properties with those of commercial Chlorella products, the cultivated algae were subjected to proximate composition analyses to determine their water, crude-protein, crude-fat, and ash-free-extract contents. Cytotoxicity was assessed via MTT and WST-1 assays, and an acute toxicity study was performed in Sprague–Dawley rats to evaluate physiological effects according to body weight changes and serum biomarkers. Histopathological examination of the liver, kidneys, and lungs was conducted to detect any toxicological effects. Additionally, antibiotic residues, microbial safety, pesticide contamination, and heavy-metal content were evaluated to confirm overall product safety.Results: Proximate analysis revealed significant differences in moisture and crude-fat content compared to commercial Chlorella products. Cytotoxicity assays demonstrated enhanced immune cell activity at higher concentrations (p<0.05). No significant body weight changes were detected in rats, and serum analysis indicated a dose-dependent reduction in alkaline phosphatase levels in 1,000- and 2,000-mg/mL treatment groups (p<0.05 and p<0.01, respectively). Histopathological examination confirmed the absence of significant alterations in the liver, kidneys, and lungs, supporting its safety as a dietary supplement. Antibiotic residue, microbial safety, pesticide contamination, and heavy-metal analyses showed levels that were undetectable or below safety limits, confirming the safety of C. fusca.Conclusion: C. fusca cultivated with refined liquid fertilizer derived from swine manure was found to be safe for use in various biotechnology applications. Our findings imply its potential as a bioresource, including as a feed additive.
- 1 February 2026
- Published by Asian Australasian Association of Animal Production Societies in Animal Bioscience
- Vol. 39 (2) , 250478
Open AccessAssessment of the safety of Chlorella fusca grown in refined swine manure liquid fertilizer for bioresource applications
Objective: Chlorella fusca, a microalga with promising applications in sustainable biotechnology, is of growing interest for its nutritional value, environmental benefits, and bioactive properties. This study investigated the safety and viability of cultivating C. fusca in refined liquid fertilizer derived from pig manure.Methods: Refined liquid fertilizer derived from swine manure was used as a nutrient medium for cultivating C. fusca. To compare its biochemical properties with those of commercial Chlorella products, the cultivated algae were subjected to proximate composition analyses to determine their water, crude-protein, crude-fat, and ash-free-extract contents. Cytotoxicity was assessed via MTT and WST-1 assays, and an acute toxicity study was performed in Sprague–Dawley rats to evaluate physiological effects according to body weight changes and serum biomarkers. Histopathological examination of the liver, kidneys, and lungs was conducted to detect any toxicological effects. Additionally, antibiotic residues, microbial safety, pesticide contamination, and heavy-metal content were evaluated to confirm overall product safety.Results: Proximate analysis revealed significant differences in moisture and crude-fat content compared to commercial Chlorella products. Cytotoxicity assays demonstrated enhanced immune cell activity at higher concentrations (p<0.05). No significant body weight changes were detected in rats, and serum analysis indicated a dose-dependent reduction in alkaline phosphatase levels in 1,000- and 2,000-mg/mL treatment groups (p<0.05 and p<0.01, respectively). Histopathological examination confirmed the absence of significant alterations in the liver, kidneys, and lungs, supporting its safety as a dietary supplement. Antibiotic residue, microbial safety, pesticide contamination, and heavy-metal analyses showed levels that were undetectable or below safety limits, confirming the safety of C. fusca.Conclusion: C. fusca cultivated with refined liquid fertilizer derived from swine manure was found to be safe for use in various biotechnology applications. Our findings imply its potential as a bioresource, including as a feed additive.
- Open Access
- 27 August 2025
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 58 (4) , 615-623
Elevated osteopontin reflects systemic inflammation in experimental autoimmune encephalomyelitis
Sungmoo Hong*, Kyungsook Jung*, Taeyoung Kang, Meejung Ahn, Changjong Moon, Jeongtae Kim, Taekyun Shin. Anat Cell Biol -0001;0:. https://doi.org/10.5115/acb.25.132
- 27 August 2025
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 58 (4) , 615-623
Open AccessElevated osteopontin reflects systemic inflammation in experimental autoimmune encephalomyelitis
Sungmoo Hong*, Kyungsook Jung*, Taeyoung Kang, Meejung Ahn, Changjong Moon, Jeongtae Kim, Taekyun Shin. Anat Cell Biol -0001;0:. https://doi.org/10.5115/acb.25.132
- Open Access
- 23 May 2025
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 58 (3) , 483-488
A potential interference of chemoreception in inflamed vomeronasal organ with experimental autoimmune encephalomyelitis
Inflammation of the vomeronasal organ (VNO) was evaluated in the context of experimental autoimmune encephalomyelitis (EAE). The VNO was sampled in mice with myelin oligodendrocyte glycoprotein-induced EAE, and processed for paraffin embedding. The sections were immunohistochemically evaluated for various markers, including ionized calcium binding adaptor molecule 1 (Iba1), myeloperoxidase (MPO), and olfactory marker protein (OMP). Inflammatory cell infiltration was detected in the connective tissues. Both Iba1-positive macrophages and MPO-positive neutrophils infiltrated the VNO of EAE, with increased secretion of mucus into the lumen. The intensity of the OMP-positive immunoreaction was decreased in the vomeronasal sensory epithelium of EAE-induced mice. We postulate that the inflammatory response of the VNO in EAE is associated with dysfunction of the accessory olfactory system.
- 23 May 2025
- Published by Korean Association of Anatomists in Anatomy & Cell Biology
- Vol. 58 (3) , 483-488
Open AccessA potential interference of chemoreception in inflamed vomeronasal organ with experimental autoimmune encephalomyelitis
Inflammation of the vomeronasal organ (VNO) was evaluated in the context of experimental autoimmune encephalomyelitis (EAE). The VNO was sampled in mice with myelin oligodendrocyte glycoprotein-induced EAE, and processed for paraffin embedding. The sections were immunohistochemically evaluated for various markers, including ionized calcium binding adaptor molecule 1 (Iba1), myeloperoxidase (MPO), and olfactory marker protein (OMP). Inflammatory cell infiltration was detected in the connective tissues. Both Iba1-positive macrophages and MPO-positive neutrophils infiltrated the VNO of EAE, with increased secretion of mucus into the lumen. The intensity of the OMP-positive immunoreaction was decreased in the vomeronasal sensory epithelium of EAE-induced mice. We postulate that the inflammatory response of the VNO in EAE is associated with dysfunction of the accessory olfactory system.
- Open Access
Inhibition of Melanogenesis via Passive Immune Targeted Alpha-MSH Binder Polypeptide
Alpha-melanocyte stimulating hormone (α-MSH) is a hormone that stimulates the formation of melanin, which is responsible for protecting the skin from UV rays. However, excessive production of melanin causes pigmentation, leading to skin disorders, such as melasma and freckles. Using phage display technology, we screened a modified hagfish VLRB (α-MSH target binding polypeptide) library for polypeptides that recognize α-MSH. This was expressed in E. coli to produce binding proteins that specifically bind to α-MSH. In this study, we investigated the effect of α-MSH binder protein on the inhibition of melanogenesis in B16F10 cells stimulated with α-MSH and the mechanism of inhibition. The α-MSH-induced inhibition of intracellular and extracellular melanogenesis was accompanied by the downregulation of TRP1 and TRP2, and melanogenesis-related proteins, such as tyrosinase and MITF, were significantly downregulated. These results suggest that the α-MSH binder polypeptide regulates melanogenesis inhibition and its associated mechanisms.
Open AccessInhibition of Melanogenesis via Passive Immune Targeted Alpha-MSH Binder Polypeptide
Alpha-melanocyte stimulating hormone (α-MSH) is a hormone that stimulates the formation of melanin, which is responsible for protecting the skin from UV rays. However, excessive production of melanin causes pigmentation, leading to skin disorders, such as melasma and freckles. Using phage display technology, we screened a modified hagfish VLRB (α-MSH target binding polypeptide) library for polypeptides that recognize α-MSH. This was expressed in E. coli to produce binding proteins that specifically bind to α-MSH. In this study, we investigated the effect of α-MSH binder protein on the inhibition of melanogenesis in B16F10 cells stimulated with α-MSH and the mechanism of inhibition. The α-MSH-induced inhibition of intracellular and extracellular melanogenesis was accompanied by the downregulation of TRP1 and TRP2, and melanogenesis-related proteins, such as tyrosinase and MITF, were significantly downregulated. These results suggest that the α-MSH binder polypeptide regulates melanogenesis inhibition and its associated mechanisms.
- Open Access
- 30 September 2024
- Published by The Korean Society of Veterinary Science (KJVR) in Korean Journal of Veterinary Research
- Vol. 64 (3) , e29
Catechin reduces liver inflammation by regulating Kupffer cell activation in rats
The liver is a defense against infections due to its strategic location between the gastrointestinal and systemic circulations. In dogs and cats, infectious hepatitis encompasses a range of contagious diseases affecting the liver either directly or as part of a broader systemic infection, including bacterial, mycobacterial, viral, fungal, protozoal, parasitic, and rickettsial diseases. Catechins possess well-recognized natural antioxidant properties. This study investigated their therapeutic potential for applications in hepatology, evaluating whether catechins reduce hepatic inflammation in rats repeatedly exposed to carbon tetrachloride (CCl4). Sprague-Dawley rats were given catechin 50 (C50) or 100 (C100) mg/kg body weight orally daily for 3 days. This treatment was given with or without concurrent intraperitoneal injections of CCl4. Phosphate-buffered saline served as the vehicle control, while silymarin administered at 100 mg/kg was used as the positive control.Gross examination revealed significant enlargement, edema, and darker tissue in CCl4-induced livers treated with vehicle. Additionally, spotty discoloration was observed on the surface. Kupffer cell activation suppressed the expression of inflammatory mediators, including inducible nitric oxide synthase (iNOS), in groups co-treated with catechin and CCl4; this effect was reversed when catalase replaced catechin in CCl4-injured rats. Catechin alleviates hepatic inflammation in rats repeatedly exposed to CCl4; it also modulates the activation of Kupffer cells and monocytes. These results should lead to new treatments for liver inflammation in veterinary practice.
- 30 September 2024
- Published by The Korean Society of Veterinary Science (KJVR) in Korean Journal of Veterinary Research
- Vol. 64 (3) , e29
Open AccessCatechin reduces liver inflammation by regulating Kupffer cell activation in rats
The liver is a defense against infections due to its strategic location between the gastrointestinal and systemic circulations. In dogs and cats, infectious hepatitis encompasses a range of contagious diseases affecting the liver either directly or as part of a broader systemic infection, including bacterial, mycobacterial, viral, fungal, protozoal, parasitic, and rickettsial diseases. Catechins possess well-recognized natural antioxidant properties. This study investigated their therapeutic potential for applications in hepatology, evaluating whether catechins reduce hepatic inflammation in rats repeatedly exposed to carbon tetrachloride (CCl4). Sprague-Dawley rats were given catechin 50 (C50) or 100 (C100) mg/kg body weight orally daily for 3 days. This treatment was given with or without concurrent intraperitoneal injections of CCl4. Phosphate-buffered saline served as the vehicle control, while silymarin administered at 100 mg/kg was used as the positive control.Gross examination revealed significant enlargement, edema, and darker tissue in CCl4-induced livers treated with vehicle. Additionally, spotty discoloration was observed on the surface. Kupffer cell activation suppressed the expression of inflammatory mediators, including inducible nitric oxide synthase (iNOS), in groups co-treated with catechin and CCl4; this effect was reversed when catalase replaced catechin in CCl4-injured rats. Catechin alleviates hepatic inflammation in rats repeatedly exposed to CCl4; it also modulates the activation of Kupffer cells and monocytes. These results should lead to new treatments for liver inflammation in veterinary practice.
- Open Access
- 30 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9462
Correlation with Apoptosis Process through RNA-Seq Data Analysis of Hep3B Hepatocellular Carcinoma Cells Treated with Glehnia littoralis Extract (GLE)
Glehnia littoralis is a perennial herb found in coastal sand dunes throughout East Asia. This herb has been reported to have hepatoprotective, immunomodulatory, antioxidant, antibacterial, antifungal, anti-inflammatory, and anticancer activities. It may be effective against hepatocellular carcinoma (HCC). However, whether this has been proven through gene-level RNA-seq analysis is still being determined. Therefore, we are attempting to identify target genes for the cell death process by analyzing the transcriptome of Hep3B cells among HCC treated with GLE (Glehnia littoralis extract) using RNA-seq. Hep3B was used for the GLE treatment, and the MTT test was performed. Hep3B was then treated with GLE at a set concentration of 300 μg/mL and stored for 24 h, followed by RNA isolation and sequencing. We then used the data to create a plot. As a result of the MTT analysis, cell death was observed when Hep3B cells were treated with GLE, and the IC50 was about 300 μg/mL. As a result of making plots using the RNA-seq data of Hep3B treated with 300 μg/mL GLE, a tendency for the apoptotic process was found. Flow cytometry and annexin V/propidium iodide (PI) staining verified the apoptosis of HEP3B cells treated with GLE. Therefore, an increase or decrease in the DEGs involved in the apoptosis process was confirmed. The top five genes increased were GADD45B, DDIT3, GADD45G, CHAC1, and PPP1R15A. The bottom five genes decreased were SGK1, CX3CL1, ZC3H12A, IER3, and HNF1A. In summary, we investigated the RNA-seq dataset of GLE to identify potential targets that may be involved in the apoptotic process in HCC. These goals may aid in the identification and management of HCC.
- 30 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9462
Open AccessCorrelation with Apoptosis Process through RNA-Seq Data Analysis of Hep3B Hepatocellular Carcinoma Cells Treated with Glehnia littoralis Extract (GLE)
Glehnia littoralis is a perennial herb found in coastal sand dunes throughout East Asia. This herb has been reported to have hepatoprotective, immunomodulatory, antioxidant, antibacterial, antifungal, anti-inflammatory, and anticancer activities. It may be effective against hepatocellular carcinoma (HCC). However, whether this has been proven through gene-level RNA-seq analysis is still being determined. Therefore, we are attempting to identify target genes for the cell death process by analyzing the transcriptome of Hep3B cells among HCC treated with GLE (Glehnia littoralis extract) using RNA-seq. Hep3B was used for the GLE treatment, and the MTT test was performed. Hep3B was then treated with GLE at a set concentration of 300 μg/mL and stored for 24 h, followed by RNA isolation and sequencing. We then used the data to create a plot. As a result of the MTT analysis, cell death was observed when Hep3B cells were treated with GLE, and the IC50 was about 300 μg/mL. As a result of making plots using the RNA-seq data of Hep3B treated with 300 μg/mL GLE, a tendency for the apoptotic process was found. Flow cytometry and annexin V/propidium iodide (PI) staining verified the apoptosis of HEP3B cells treated with GLE. Therefore, an increase or decrease in the DEGs involved in the apoptosis process was confirmed. The top five genes increased were GADD45B, DDIT3, GADD45G, CHAC1, and PPP1R15A. The bottom five genes decreased were SGK1, CX3CL1, ZC3H12A, IER3, and HNF1A. In summary, we investigated the RNA-seq dataset of GLE to identify potential targets that may be involved in the apoptotic process in HCC. These goals may aid in the identification and management of HCC.
- Open Access
- 18 January 2024
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 28 (1) , 37-44
Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
Visual impairment associated with uveitis is among the potential complications in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Bioinformatics analyses have shown that some hub genes are closely associated with the molecular mechanisms underlying uveitis in EAE. This study evaluated whether 4-allyl-2-methoxyphenol (eugenol) can mitigate the pathogenesis of uveitis in EAE through the interruption of key uveitogenic gene expression. Myelin oligodendrocyte glycoprotein35–55 (MOG) peptide-immunized C57BL/6 mice were injected intraperitoneally with eugenol. The eyeballs and spinal cords of EAE mice with or without eugenol treatment were collected simultaneously and immunohistochemical and molecular biological analyses were conducted. Eugenol treatment significantly ameliorated hindlimb paralysis. Ionized calcium-binding adapter molecule 1 (Iba-1) immunohistochemistry showed that the inflammatory response was significantly reduced in the uvea of eugenol-treated EAE mice compared with vehicle-treated controls. Eugenol also significantly reduced the expression of key uveitogenic genes including C1qb and Tyrobp. The suppressive effect of eugenol on inflammation was also observed in the spinal cord, as determined by the suppression of Iba-1-positive microglial cells. Together, these results suggest that the ameliorative effect of eugenol against EAE uveitis is associated with the suppression of key proinflammatory genes, which may represent targets for the treatment of uveitis.
- 18 January 2024
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 28 (1) , 37-44
Open AccessEugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
Visual impairment associated with uveitis is among the potential complications in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Bioinformatics analyses have shown that some hub genes are closely associated with the molecular mechanisms underlying uveitis in EAE. This study evaluated whether 4-allyl-2-methoxyphenol (eugenol) can mitigate the pathogenesis of uveitis in EAE through the interruption of key uveitogenic gene expression. Myelin oligodendrocyte glycoprotein35–55 (MOG) peptide-immunized C57BL/6 mice were injected intraperitoneally with eugenol. The eyeballs and spinal cords of EAE mice with or without eugenol treatment were collected simultaneously and immunohistochemical and molecular biological analyses were conducted. Eugenol treatment significantly ameliorated hindlimb paralysis. Ionized calcium-binding adapter molecule 1 (Iba-1) immunohistochemistry showed that the inflammatory response was significantly reduced in the uvea of eugenol-treated EAE mice compared with vehicle-treated controls. Eugenol also significantly reduced the expression of key uveitogenic genes including C1qb and Tyrobp. The suppressive effect of eugenol on inflammation was also observed in the spinal cord, as determined by the suppression of Iba-1-positive microglial cells. Together, these results suggest that the ameliorative effect of eugenol against EAE uveitis is associated with the suppression of key proinflammatory genes, which may represent targets for the treatment of uveitis.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Veterinary Science
- Vol. 25 (5) , e69
Lithium alleviates paralysis in experimental autoimmune neuritis in Lewis rats by modulating glycogen synthase kinase-3β activity
Ahn M. J Vet Sci. 2024 Sep;25:e69. https://doi.org/10.4142/jvs.24212
- 1 January 2024
- Published by XMLink in Journal of Veterinary Science
- Vol. 25 (5) , e69
Open AccessLithium alleviates paralysis in experimental autoimmune neuritis in Lewis rats by modulating glycogen synthase kinase-3β activity
Ahn M. J Vet Sci. 2024 Sep;25:e69. https://doi.org/10.4142/jvs.24212
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Veterinary Science
- Vol. 25 (3) , e35
Histopathological evaluation of the lungs in experimental autoimmune encephalomyelitis
Hong S, et al. J Vet Sci. 2024 Apr;25(3):e35. https://doi.org/10.4142/jvs.23302
- 1 January 2024
- Published by XMLink in Journal of Veterinary Science
- Vol. 25 (3) , e35
Open AccessHistopathological evaluation of the lungs in experimental autoimmune encephalomyelitis
Hong S, et al. J Vet Sci. 2024 Apr;25(3):e35. https://doi.org/10.4142/jvs.23302
- Open Access
- 31 December 2023
- Published by Wiley in Advanced Science
- Vol. 11 (11) , e2307148
Antibody‐Conjugated Magnetic Nanoparticle Therapy for Inhibiting T‐Cell Mediated Inflammation
Tolerance induction is critical for mitigating T cell‐mediated inflammation. Treatments based on anti‐CD3 monoclonal antibody (mAb) play a pivotal role in inducing such tolerance. Anti‐CD3 mAb conjugated with dextran‐coated magnetic nanoparticles (MNPs) may induce inflammatory tolerance is posited. MNPs conjugated with anti‐CD3 mAb (Ab‐MNPs) are characterized using transmission and scanning electron microscopy, and their distribution is assessed using a nanoparticle tracking analyzer. Compared to MNPs, 90% of Ab‐MNPs increased in size from 54.7 ± 0.5 to 71.7 ± 2.7 nm. The in vitro and in vivo studies confirmed the therapeutic material as nontoxic and biocompatible. Mice are administered various dosages of Ab‐MNPs before receiving concanavalin‐A (ConA), an inflammation inducer. Preadministration of Ab‐MNPs, as opposed to MNPs or anti‐CD3 mAb alone, significantly reduced the serum levels of interferon‐γ and interleukin‐6 in ConA‐treated mice. Additionally, the transdermal stamp patch as an effective delivery system for Ab‐MNPs is validated. This study demonstrates the utility of the Ab‐MNP complex in pathologies associated with T cell‐mediated hyperinflammation, such as organ transplantation and COVID‐19.
- 31 December 2023
- Published by Wiley in Advanced Science
- Vol. 11 (11) , e2307148
Open AccessAntibody‐Conjugated Magnetic Nanoparticle Therapy for Inhibiting T‐Cell Mediated Inflammation
Tolerance induction is critical for mitigating T cell‐mediated inflammation. Treatments based on anti‐CD3 monoclonal antibody (mAb) play a pivotal role in inducing such tolerance. Anti‐CD3 mAb conjugated with dextran‐coated magnetic nanoparticles (MNPs) may induce inflammatory tolerance is posited. MNPs conjugated with anti‐CD3 mAb (Ab‐MNPs) are characterized using transmission and scanning electron microscopy, and their distribution is assessed using a nanoparticle tracking analyzer. Compared to MNPs, 90% of Ab‐MNPs increased in size from 54.7 ± 0.5 to 71.7 ± 2.7 nm. The in vitro and in vivo studies confirmed the therapeutic material as nontoxic and biocompatible. Mice are administered various dosages of Ab‐MNPs before receiving concanavalin‐A (ConA), an inflammation inducer. Preadministration of Ab‐MNPs, as opposed to MNPs or anti‐CD3 mAb alone, significantly reduced the serum levels of interferon‐γ and interleukin‐6 in ConA‐treated mice. Additionally, the transdermal stamp patch as an effective delivery system for Ab‐MNPs is validated. This study demonstrates the utility of the Ab‐MNP complex in pathologies associated with T cell‐mediated hyperinflammation, such as organ transplantation and COVID‐19.